Diet and Nutrients in Gastrointestinal Chronic Diseases

Corsello, Antonio; Pugliese, Daniela; Gasbarrini, Antonio; Armuzzi, Alessandro

doi:10.3390/nu12092693

Cited by 48 publications

(30 citation statements)

References 154 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Complementary and alternative treatments have been reported as beneficial in treating FD symptoms [ 27 ], and may thereby enhance the effectiveness of dietary management strategies. Four trials have reported that supplements containing peppermint and caraway oil were more effective than placebo in improving dyspeptic symptoms, with an average decreased intensity of epigastric pain compared to placebo [ 4 , 111 , 112 , 113 ].…”

Section: Complementary Therapies and Micronutrient Supplementation In Dietary Management Of Fdmentioning

confidence: 99%

“…FD is a disorder of symptoms and subtle immune changes, so the overarching goal of dietetic management is to complement medical therapy by using dietary modification to alleviate symptoms. Currently, guidance for dietetic management of FD is limited to a focus on frequent small meals, and possible trialing of reduced dietary fat intake to ameliorate slow gastric motility [ 27 ]. Due to the multifaceted nature of FD and broad range of presentation scenarios for people seeking dietary management advice for the condition, we believe that a differential dietary management approach for FD is needed.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia

et al. 2021

View full text Add to dashboard Cite

Functional dyspepsia (FD) is a common disorder of gut-brain interaction, characterised by upper gastrointestinal symptom profiles that differentiate FD from the irritable bowel syndrome (IBS), although the two conditions often co-exist. Despite food and eating being implicated in FD symptom induction, evidence-based guidance for dietetic management of FD is limited. The aim of this narrative review is to collate the possible mechanisms for eating-induced and food-related symptoms of FD for stratification of dietetic management. Specific carbohydrates, proteins and fats, or foods high in these macronutrients have all been reported as influencing FD symptom induction, with removal of ‘trigger’ foods or nutrients shown to alleviate symptoms. Food additives and natural food chemicals have also been implicated, but there is a lack of convincing evidence. Emerging evidence suggests the gastrointestinal microbiota is the primary interface between food and symptom induction in FD, and is therefore a research direction that warrants substantial attention. Objective markers of FD, along with more sensitive and specific dietary assessment tools will contribute to progressing towards evidence-based dietetic management of FD.

show abstract

Section: Complementary Therapies and Micronutrient Supplementation In Dietary Management Of Fdmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The Crohn’s Disease Exclusion Diet (CDED) is a validated dietary intervention, firstly conceived in 2014 by Sigall-Boneh and colleagues, combining PEN with a specific exclusion diet [ 69 ]. The rationale of CDED is the avoidance of certain foods and dietary components (such as additives like emulsifiers or maltodextrins, food preservatives, etc), mostly belonging to western diets, deemed to act as triggers for intestinal inflammation, dysbiosis, altered intestinal mucous layer and impaired barrier function [ 12 , 21 , 22 , 70 , 71 ]. In addition, the use of real foods, even though in a controlled way, seems to meet the request of patients and their parents, often blaming the monotony of EEN as responsible for a low adherence to treatment [ 72 , 73 ].…”

Section: Nutritional Strategies In Induction Of Remission In Pediamentioning

confidence: 99%

Diet and Nutrition in Pediatric Inflammatory Bowel Diseases

2021

View full text Add to dashboard Cite

Both genetic and environmental factors are involved in the onset of inflammatory bowel disease (IBD). In particular, diet composition is suspected to significantly contribute to IBD risk. In recent years, major interest has raised about the role of nutrition in disease pathogenesis and course, and many studies have shown a clear link between diet composition and intestinal permeability impairment. Moreover, many IBD-related factors, such as poor dietary intake, nutrients loss and drugs interact with nutritional status, thus paving the way for the development of many therapeutic strategies in which nutrition represents the cornerstone, either as first-line therapy or as reversing nutritional deficiencies and malnutrition in IBD patients. Exclusive enteral nutrition (EEN) is the most rigorously supported dietary intervention for the treatment of Crohn’s Disease (CD), but is burdened by a low tolerability, especially in pediatric patients. Promising alternative regimens are represented by Crohn’s Disease Exclusion Diet (CDED), and other elimination diets, whose use is gradually spreading. The aim of the current paper is to provide a comprehensive and updated overview on the latest evidence about the role of nutrition and diet in pediatric IBD, focusing on the different nutritional interventions available for the management of the disease.

show abstract

“…Moreover, it seems that the use of elementary formulas with a low lipid content can be better tolerated by SMA1 children. In particular, all patients who have an abnormal gastric emptying can benefit from low-fat diet, which can help to improve motility and reflux [ 58 ]. Unfortunately, additional data are needed to confirm these benefits.…”

Section: Nutritional Aspects: Critical Issues and Possible Solutionsmentioning

confidence: 99%

Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1

et al. 2021

Self Cite

View full text Add to dashboard Cite

The management of patients with spinal muscular atrophy type 1 (SMA1) is constantly evolving. In just a few decades, the medical approach has switched from an exclusively palliative therapy to a targeted therapy, transforming the natural history of the disease, improving survival time and quality of life and creating new challenges and goals. Many nutritional problems, gastrointestinal disorders and metabolic and endocrine alterations are commonly identified in patients affected by SMA1 during childhood and adolescence. For this reason, a proper pediatric multidisciplinary approach is then required in the clinical care of these patients, with a specific focus on the prevention of most common complications. The purpose of this narrative review is to provide the clinician with a practical and usable tool about SMA1 patients care, through a comprehensive insight into the nutritional, gastroenterological, metabolic and endocrine management of SMA1. Considering the possible horizons opened thanks to new therapeutic frontiers, a nutritional and endo-metabolic surveillance is a crucial element to be considered for a proper clinical care of these patients.

show abstract

Diet and Nutrients in Gastrointestinal Chronic Diseases

Cited by 48 publications

References 154 publications

Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia

Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia

Diet and Nutrition in Pediatric Inflammatory Bowel Diseases

Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1

Contact Info

Product

Resources

About